COVID-19: China Healthcare Implications for Private Equity Investors

Stephen Sunderland

china healthcare implications

drive practical insight

economic activity index

healthcare opening

corporate data

proprietary survey

trajectory survey

important pivots

pivots impact

AI broadly utilized

robotic industry

telehealth impact

remote solutions

financial pain

self succiency

supply chain disruptive

positive views

innovative biopharma

parallel innovation

cell therapy

temporary growth

medtech market

faster recovery

china changed landscape

global investors

connect

disclaimer

Related Insights

Healthcare Services • Published Articles

Delivering Healthcare at the Touch of a Button

September 10, 2021

Life Sciences & Pharma • Special Report

Making the AI Leap: Boosting Singapore’s Competitiveness in Biotech

December 17, 2020

Following years of investment through artificial intelligence (AI)-centric venture funds and government grants, Singapore has moved beyond applying AI to…

Life Sciences & Pharma • Executive Insights

Preparedness, Policy And Patients – Learning From The Pandemic

May 19, 2021

We must ask what we have learnt from our recent experiences that can be deployed to help accelerate approaches to fighting other, similarly devastating,…

Life Sciences & Pharma • Video / Webinar

Webinar Recording — Life Sciences: What To Expect in 2021

January 28, 2021

Join experts from L.E.K. Consulting as they present their insights into recent trends and expected changes to the life sciences sector this year.

Life Sciences & Pharma • Special Report

Unlocking the Benefits of Patient-Centric Healthcare

June 16, 2021

Many organizations have adopted patient-centric healthcare (PCH) over the years, although some have been challenged to deliver on the full potential of…

Life Sciences & Pharma • Article

ASCO 2021 Social Listening: Major Data Readouts and Themes

July 27, 2021

L.E.K. Consulting used social listening to gauge the sentiment of virtual attendees at the ASCO 2021 meeting.